What is Factor XIII Deficiency

Factor XIII Deficiency is a rare, life-threatening blood clotting disorder characterized by the body's inability to form stable blood clots, leading to delayed or persistent bleeding. Unlike other clotting factor deficiencies, individuals with Factor XIII Deficiency often have normal results on standard screening tests, which can complicate and delay the diagnosis.

What is the underlying cause of Factor XIII Deficiency?

Blood clotting is a complex process; Factor XIII acts as the "stabilizer" that cross-links fibrin strands to harden a clot. In Factor XIII Deficiency, this final step of the coagulation cascade fails. This is typically an autosomal recessive genetic condition, meaning a person must inherit a mutated gene from both parents to develop the clinical disease. Because it is genetic, the condition is present from birth, though symptoms may manifest at different life stages.

How common is Factor XIII Deficiency?

Factor XIII Deficiency is extremely rare, with a global prevalence estimated at approximately 1 in 1 to 2 million people. Because it is an autosomal recessive condition, it is more frequently diagnosed in populations with higher rates of consanguinity (marriages between close relatives), where the likelihood of inheriting two copies of the mutated gene is statistically higher.

What are the primary symptoms of Factor XIII Deficiency?

The hallmark of Factor XIII Deficiency is abnormal bleeding that often occurs hours or even days after an injury, rather than immediately. Common clinical presentations include:

• Umbilical cord bleeding at birth (a classic indicator).


• Spontaneous intracranial hemorrhage (bleeding in the brain), which is the most serious complication.


• Poor wound healing and recurrent soft tissue hematomas.


• Severe or prolonged menstrual bleeding (menorrhagia) in females.


• Recurrent miscarriages due to the inability to maintain the fibrin structure necessary for placental attachment.

How is this condition different from other bleeding disorders?

Most bleeding disorders, such as Hemophilia, show abnormal results on standard "coagulation panels" like the PT or PTT. Factor XIII Deficiency is unique because standard screening tests are almost always normal. Specialized quantitative or functional assays are required to measure Factor XIII activity levels specifically, which is why clinical suspicion must remain high if a patient has a severe bleeding history despite normal routine labs.

Next steps

• Consult a hematologist specializing in rare coagulation disorders to discuss specialized testing.


• Connect with the 5 members of our community at DiseaseMaps.org who are currently managing Factor XIII Deficiency.


• Maintain a detailed "bleeding diary" to track the frequency and severity of symptoms for your medical team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Factor XIII deficiency.


• Orphanet: Congenital factor XIII deficiency.


• OMIM (Online Mendelian Inheritance in Man): Factor XIII deficiency entry #613225.


• World Federation of Hemophilia (WFH) Guidelines on rare bleeding disorders.